InsidersTradesSigma
Follow the PHARMANUTRA CS stock price and the full management transaction log of the company, a publicly traded company based in Italy. Shares trade on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA CS has published 1 reports. Market capitalisation: €804.3m. The latest transaction was disclosed on 24 July 2024 (Other). The full history is openly available.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,445 of 29,063 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2024
关于 PHARMANUTRA CS
PHARMANUTRA CS 是一家在XMIL市场上市的健康和制药领域的公司。它专注于营养保健品和药品的开发和营销。